Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Imclone systems (IMCL) -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (318)	2/25/1999 9:45:00 PM
From: QuietWon	Read Replies (1) \| Respond to of 2515

Thx, tuck. In layman's term in explaining how IMCL approached it, consider than IMCL is able to target the drug to the specific area. Chemotherapy works on the whole body and destroys good cells as well as cancerous one. IMCL's works at the area where the cancerous cell are. And along with moderate, only moderate chemo. Thereby, preserving the non-cancerous cells. Just a simplification. I am researching another biotechnology which I think can also be a significant player in the biotech arena. I am surprised it hasn't caught on. But then again, it is taking so long for ppl to wake up and realize IMCL is dman good, that it is no wonder the other co is not doing better in its stock price. Rem as I have always said, a company and its stock, are two different animals. Good trading, tuck !